The efficacy and safety of estriol to treat vulvovaginal atrophy in postmenopausal women: a systematic literature review

References

• Portman DJ, Gass ML. Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society. Climacteric 2014;17:557–63
   PubMed Web of Science ®Google Scholar
• Takahashi T, Johnson K. Menopause. Med Clin N Am 2015;99:521–34
   PubMed Web of Science ®Google Scholar
• Blake J. Menopause: evidence-based practice. Best Pract Res Clin Obstet Gynaecol 2006;20:799–893
   PubMed Web of Science ®Google Scholar
• Management of symptomatic vulvovaginal atrophy: 2013 position statement of the North American Menopause Society. Menopause 2013;20:888–902
   PubMed Web of Science ®Google Scholar
• Baumgart J, Nilsson K, Stavreus-Evers A, et al. Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer. Am J Obstet Gynecol 2011;204:26.e1–7
   PubMed Web of Science ®Google Scholar
• Sturdee DW, Panay N. International Menopause Society Writing Group. Recommendations for the management of vaginal atrophy in postmenopausal women. Climacteric 2010;13:509–22
   PubMed Web of Science ®Google Scholar
• Loibl S, Lintermands A, Dieudonné A, Neven O. Management of menopausal symptoms in breast cancer patients. Maturitas 2011;68:148–54
   PubMed Web of Science ®Google Scholar
• Ettinger B, Hait H, Reape K, Shu H. Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach. Menopause 2008;5:885–9
   Web of Science ®Google Scholar
• Suckling J, Kennedy R, Lethaby A, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2006;Vol 4:CD001500
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. UK and Australia. Available from www.cochrane-handbook.org
   Google Scholar
• GRADEpro. [Computer program on www.gradepro.org]. McMaster University, 2014
   Google Scholar
• Lose G, Englev E. Oestradiol-releasing vaginal ring versus vaginal estriol pessaries in the treatment of bothersome lower urinary tract symptoms. Br J Obstet Gynecol 2000;107:1029–34
   Google Scholar
• Capobianco G, Borghero G, Cherchi P. Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women. Arch Gynecol Obstet 2012;285:397–403
   PubMed Web of Science ®Google Scholar
• Dessole S, Rubattu G, Ambrosini G, et al. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Menopause 2004;11:49–56
   PubMed Web of Science ®Google Scholar
• Raz R, Stamm W. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993;329:753–6
   PubMed Web of Science ®Google Scholar
• Zullo M, Poli F, Calcagno M, et al. Vaginal estrogen therapy and overactive bladder symptoms in postmenopausal patients after a tension-free vaginal tape procedure: a randomized clinical trial. Menopause 2005;12:421–7
   PubMed Web of Science ®Google Scholar
• Henriksson L, Sgemquist M, Boquist L, Alander U, Selinus IA. Comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus vaginal estriol pessaries in postmenopausal women with symptoms and signs of urogenital atrophy. Am J Obstet Gynecol 1994;171:624–32
   PubMed Web of Science ®Google Scholar
• Dugal A, Hesla K, Sørdal T, Aase K, Lilleeidet O, Wickstrøm E. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy. Acta Obstet Gynecol Scand 2000;79:293–7
   PubMed Web of Science ®Google Scholar
• Iosif C. Effects of protracted administration of estriol on the lower genito urinary tract in postmenopausal women. Arch Gynecol Obstet 1992;251:115–20
   PubMed Web of Science ®Google Scholar
• Haspels A, Luisi M, Kicovic P. Endocrinological and clinical investigations in post-menopausal women following administration of vaginal cream containing oestriol. Maturitas 1981;3:321–7
   PubMed Web of Science ®Google Scholar
• Chollet J, Carter G, Meyn L, Mermelstein F, Balk J. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis. Menopause 2009;16:978–83
   PubMed Web of Science ®Google Scholar
• Mattsson L, Cullberg G. A clinical evaluation of treatment with estriol vaginal cream versus suppository in postmenopausal women. Acta Obstet Gynecol Scand 1983;62:397–401
   PubMed Web of Science ®Google Scholar
• Kicovic P, Cortes-Prieto J, Milojevic S, Haspels A, Aljinovic A. The treatment of postmenopausal vaginal atrophy with ovestin vaginal cream or pessaries: clinical, endocrinological and safety aspects. Maturitas 1980;2:275–82
   PubMed Web of Science ®Google Scholar
• Batra S, Iosif S. Progesterone receptors in vaginal tissue of post-menopausal women. Maturitas 1987;9:87–93
   PubMed Web of Science ®Google Scholar
• Keller P, Riedmann R, Fischer M, Gerber C. Oestrogens, gonadotropins and prolactin after intra-vaginal administration of oestriol in post-menopausal women. Maturitas 1981;3:47–53
   PubMed Web of Science ®Google Scholar
• Heimer G, Englund D. Estriol: absorption after long-term vaginal treatment and gastrointestinal absorption as influenced by a meal. Acta Obstet Gynecol Scand 1984;63:563–7
   PubMed Web of Science ®Google Scholar
• Van Haaften M, Dinker H, Haspels A, Thijssen H. Oestrogen concentrations in plasma, endometrium, myometrium and vagina of postmenopausal women, and effects of vaginal oestriol (E3) and oestradiol (E2) applications. J Steroid Biochem 1989;33:647–53
   PubMedGoogle Scholar
• Punnonen R, Vilska S, Gronroos M, Rauramo L. The vaginal absorption of oestrogens in post-menopausal women. Maturitas 1980;2:321–6
   PubMed Web of Science ®Google Scholar
• Mattsson L, Cullberg G. Vaginal absorption of two estriol preparations: a comparative study in postmenopausal women. Acta Obstet Gynecol Scand 1983;62:393–6
   PubMed Web of Science ®Google Scholar
• Heimer G, Englund D. Plasma oestriol following vaginal administration: morning versus evening insertion and influence of food. Maturitas 1986;8:239–43
   PubMed Web of Science ®Google Scholar
• Englund D, Axelsson O, Nilsson O. Endometrial effect of vaginal estriol treatment: a scanning electron microscopic study of the luminal surface. Acta Obstet Gynecol Scand Suppl 1981;106:23–6
   PubMedGoogle Scholar
• Gerbaldo D, Ferraiolo A, Crocea S, Tminib M, Capitanio G. Endometrial morphology after 12 months of vaginal oestriol therapy in post-menopausal women. Maturitas 1991;13:269–74
   PubMed Web of Science ®Google Scholar
• Van Haaften M, Donker G, Sie-Go D, Haspels A, Thijssen H. Biochemical and histological effects of vaginal estriol and estradiol applications on the endometrium, myometrium and vagina of postmenopausal women. Gynecol Endocrinol 1997;11:175–85
   PubMed Web of Science ®Google Scholar
• Lyytinen H, Pukkala E, Ylikorkala O. Breast cancer risk in postmenopausal women using estrogen-only therapy. Obstet Gynecol 2006;108:1354–60
   PubMed Web of Science ®Google Scholar
• Baber R, Panay N, Fenton A. 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric 2016;19:109–50
   PubMed Web of Science ®Google Scholar